Royal Bank of Canada’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-131
Closed -$3K 7352
2023
Q2
$3K Buy
+131
New +$3K ﹤0.01% 6364
2022
Q4
Sell
-1,400
Closed -$9K 7441
2022
Q3
$9K Buy
1,400
+15
+1% +$96 ﹤0.01% 6012
2022
Q2
$15K Sell
1,385
-125
-8% -$1.35K ﹤0.01% 5765
2022
Q1
$28K Sell
1,510
-147
-9% -$2.73K ﹤0.01% 5949
2021
Q4
$60K Buy
1,657
+1,497
+936% +$54.2K ﹤0.01% 5735
2021
Q3
$12K Buy
160
+107
+202% +$8.03K ﹤0.01% 6392
2021
Q2
$7K Sell
53
-41
-44% -$5.42K ﹤0.01% 6496
2021
Q1
$27K Buy
+94
New +$27K ﹤0.01% 5769